연구성과로 돌아가기
JCR 2024 저널 목록 (1015 / 2104)
※ 컨트롤 + 클릭으로 열별 다중 정렬 가능합니다.
Excel 다운로드
| Journal Name | Publisher | ISSN | eISSN | Edition | WoS Category | Total Citation | JIF | JIF Quartile | 상위 JCR(%) | JIF % | JIF Rank | 5-Year JIF | 5-Year Quartile | JIF w/o Self-Cites | Immediacy Index | JCI | JCI Rank | JCI Quartile | JCI Percentile | Eigenfactor Score | Normalized Eigenfactor | Article Influence Score | AIS Quartile | Citable Items | Articles in Citable Items (%) | Cited Half-Life | Citing Half-Life | Total Articles | Citable OA (%) | 수집시기 | 바로가기 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| AMERICAN JOURNAL OF THERAPEUTICS | LIPPINCOTT WILLIAMS & WILKINS | 1075-2765 | 1536-3686 | SCIE | PHARMACOLOGY & PHARMACY | 2,077 | 2.5 | Q3 | 51.3 | 48.7 | 181/352 | 2.4 | Q3 | 2.3 | 1.3 | 0.61 | 198/353 | Q3 | 44.05 | 0.001 | 0.287 | 0.628 | Q2 | 45 | 84.4% | 8.3 | 8.2 | 38 | 3.9% | 2025-08-05 16:04:34 | 바로가기 |
| Applied Sciences-Basel | MDPI | N/A | 2076-3417 | SCIE | CHEMISTRY, MULTIDISCIPLINARY | 158,735 | 2.5 | Q3 | 51.3 | 48.7 | 123/239 | 2.7 | Q2 | 2.3 | 0.6 | 0.52 | 112/241 | Q2 | 53.73 | 0.181 | 40.260 | 0.438 | Q2 | 12007 | 93.3% | 3.3 | 6.0 | 11198 | 100.0% | 2025-08-05 16:02:40 | 바로가기 |
| Biochimica et Biophysica Acta-Gene Regulatory Mechanisms | ELSEVIER | 1874-9399 | 1876-4320 | SCIE | BIOCHEMISTRY & MOLECULAR BIOLOGY | 6,849 | 3.1 | Q3 | 51.3 | 48.7 | 164/319 | 4.1 | Q2 | 2.9 | 0.7 | 0.70 | 140/320 | Q2 | 56.41 | 0.004 | 0.865 | 1.297 | Q2 | 40 | 65.0% | 10.4 | 8.2 | 26 | 24.2% | 2025-08-05 16:02:32 | 바로가기 |
| CHEMICAL PAPERS | SPRINGER INT PUBL AG | 0366-6352 | 2585-7290 | SCIE | CHEMISTRY, MULTIDISCIPLINARY | 8,832 | 2.5 | Q3 | 51.3 | 48.7 | 123/239 | 2.3 | Q3 | 2.4 | 0.7 | 0.38 | 134/241 | Q3 | 44.61 | 0.006 | 1.316 | 0.282 | Q3 | 585 | 91.4% | 3.7 | 6.4 | 535 | 6.6% | 2025-08-05 16:02:40 | 바로가기 |
| CHEMISTRY & BIODIVERSITY | WILEY-V C H VERLAG GMBH | 1612-1872 | 1612-1880 | SCIE | CHEMISTRY, MULTIDISCIPLINARY | 10,622 | 2.5 | Q3 | 51.3 | 48.7 | 123/239 | 2.6 | Q3 | 2.2 | 0.7 | 0.45 | 125/241 | Q3 | 48.34 | 0.006 | 1.334 | 0.346 | Q3 | 1102 | 86.3% | 4.4 | 7.2 | 951 | 4.6% | 2025-08-05 16:02:40 | 바로가기 |
| CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY | WILEY | 0305-1870 | 1440-1681 | SCIE | PHARMACOLOGY & PHARMACY | 6,051 | 2.5 | Q3 | 51.3 | 48.7 | 181/352 | 2.3 | Q3 | 2.5 | 0.7 | 0.76 | 134/353 | Q2 | 62.18 | 0.003 | 0.567 | 0.449 | Q3 | 68 | 100.0% | 11.1 | 6.4 | 68 | 9.2% | 2025-08-05 16:04:34 | 바로가기 |
| Clinical Pharmacology-Advances and Applications | DOVE MEDICAL PRESS LTD | 1179-1438 | 1179-1438 | ESCI | PHARMACOLOGY & PHARMACY | 513 | 2.5 | Q3 | 51.3 | 48.7 | 181/352 | 2.4 | Q3 | 2.5 | 2.7 | 0.56 | 208/353 | Q3 | 41.22 | 0.000 | 0.092 | 0.640 | Q2 | 3 | 33.3% | 7.1 | 4.0 | 1 | 100.0% | 2025-08-05 16:04:35 | 바로가기 |
| COLORATION TECHNOLOGY | WILEY | 1472-3581 | 1478-4408 | SCIE | CHEMISTRY, APPLIED | 1,865 | 2.2 | Q3 | 51.3 | 48.7 | 39/75 | 2.2 | Q3 | 1.8 | 0.4 | 0.41 | 40/76 | Q3 | 48.03 | 0.001 | 0.167 | 0.288 | Q3 | 50 | 90.0% | 8.1 | 8.8 | 45 | 15.0% | 2025-08-05 16:02:39 | 바로가기 |
| CRITICAL REVIEWS IN THERAPEUTIC DRUG CARRIER SYSTEMS | BEGELL HOUSE INC | 0743-4863 | 2162-660X | SCIE | PHARMACOLOGY & PHARMACY | 1,242 | 2.5 | Q3 | 51.3 | 48.7 | 181/352 | 3.0 | Q2 | 2.1 | 1.6 | 0.34 | 283/353 | Q4 | 19.97 | 0.000 | 0.050 | 0.343 | Q4 | 18 | 0.0% | 11.8 | 9.5 | 0 | 0.0% | 2025-08-05 16:04:35 | 바로가기 |
| CURRENT DRUG TARGETS | BENTHAM SCIENCE PUBL LTD | 1389-4501 | 1873-5592 | SCIE | PHARMACOLOGY & PHARMACY | 6,259 | 2.5 | Q3 | 51.3 | 48.7 | 181/352 | 3.3 | Q2 | 2.5 | 0.4 | 0.44 | 261/353 | Q3 | 26.20 | 0.003 | 0.607 | 0.583 | Q3 | 76 | 4.0% | 8.4 | 6.5 | 3 | 1.9% | 2025-08-05 16:04:34 | 바로가기 |
| Drug Target Insights | ABOUTSCIENCE SRL | 1177-3928 | 1177-3928 | ESCI | PHARMACOLOGY & PHARMACY | 269 | 2.5 | Q3 | 51.3 | 48.7 | 181/352 | 3.3 | Q2 | 2.5 | 0.4 | 0.56 | 208/353 | Q3 | 41.22 | 0.000 | 0.045 | 0.668 | Q2 | 12 | 100.0% | 8.1 | 5.9 | 12 | 94.4% | 2025-08-05 16:04:35 | 바로가기 |
| Food Additives and Contaminants Part A-Chemistry Analysis Control Exposure & Risk Assessment | TAYLOR & FRANCIS LTD | 1944-0049 | 1944-0057 | SCIE | CHEMISTRY, APPLIED | 8,568 | 2.2 | Q3 | 51.3 | 48.7 | 39/75 | 2.8 | Q2 | 2.1 | 0.5 | 0.48 | 35/76 | Q2 | 54.61 | 0.003 | 0.565 | 0.403 | Q2 | 134 | 91.0% | 10.3 | 7.3 | 122 | 14.7% | 2025-08-05 16:02:39 | 바로가기 |
| Frontiers in Bioscience-Landmark | IMR PRESS | 2768-6701 | 2768-6698 | SCIE | BIOCHEMISTRY & MOLECULAR BIOLOGY | 11,456 | 3.1 | Q3 | 51.3 | 48.7 | 164/319 | 3.2 | Q3 | 3.0 | 0.8 | 0.44 | 252/320 | Q4 | 21.41 | 0.005 | 1.140 | 0.622 | Q3 | 412 | 68.0% | 12.4 | 6.4 | 280 | 98.7% | 2025-08-05 16:02:32 | 바로가기 |
| FUNDAMENTAL & CLINICAL PHARMACOLOGY | WILEY | 0767-3981 | 1472-8206 | SCIE | PHARMACOLOGY & PHARMACY | 3,094 | 2.5 | Q3 | 51.3 | 48.7 | 181/352 | 2.5 | Q3 | 2.4 | 0.6 | 0.62 | 195/353 | Q3 | 44.90 | 0.002 | 0.415 | 0.493 | Q3 | 57 | 75.4% | 8.5 | 8.8 | 43 | 12.6% | 2025-08-05 16:04:34 | 바로가기 |
| GLYCOCONJUGATE JOURNAL | SPRINGER | 0282-0080 | 1573-4986 | SCIE | BIOCHEMISTRY & MOLECULAR BIOLOGY | 2,799 | 3.1 | Q3 | 51.3 | 48.7 | 164/319 | 3.1 | Q3 | 3.1 | 0.8 | 0.48 | 241/320 | Q4 | 24.84 | 0.001 | 0.294 | 0.620 | Q3 | 26 | 65.4% | 9.0 | 9.3 | 17 | 22.0% | 2025-08-05 16:02:32 | 바로가기 |
페이지 이동: